+218.1%
MRNA vs EXPD
+75.3%
+142.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EXPD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.4% | -3.0% | -3.2% |
| 7D | -12.1% | +5.5% | -17.6% | -14.4% |
| 30D | -1.3% | -0.8% | -0.5% | -1.0% |
| 3M | +250.9% | +4.1% | +246.8% | +243.2% |
| 6M | +343.0% | +25.7% | +317.3% | +292.2% |
| YTD | +657.4% | +31.4% | +626.0% | +539.9% |
| 1Y | +794.9% | +42.2% | +752.7% | +619.6% |
| 3Y | +218.1% | +77.2% | +141.0% | +114.9% |
| All | +218.1% | +75.3% | +142.9% | +114.9% |
Cumulative growth
Daily Returns
Daily percentage return beside EXPD.
Daily Out/Under-Performance
Portfolio return minus EXPD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EXPD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EXPD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling